Home/Filings/4/0001415889-23-006301
4//SEC Filing

Sorg Elaine K. 4

Accession 0001415889-23-006301

CIK 0001551152other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 5:00 PM ET

Size

9.0 KB

Accession

0001415889-23-006301

Insider Transaction Report

Form 4
Period: 2023-04-03
Sorg Elaine K.
Sr. V.P., U.S. Commercial Ops.
Transactions
  • Sale

    Common Stock, $0.01 par value

    2023-04-03$160.03/sh15,002$2,400,77042,829 total
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2023-04-03$93.50/sh+15,002$1,402,68757,831 total
  • Exercise/Conversion

    Option (Right to Buy)

    2023-04-03$93.50/sh15,002$1,402,6870 total
    Exercise: $93.50From: 2021-02-20Exp: 2030-02-19Common Stock (15,002 underlying)
Footnotes (2)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.05, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001832571

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:00 PM ET
Size
9.0 KB